BLU-945 Monotherapy and Combination With Osimertinib in Previously Treated Patients With Advanced EGFR-Mutant (EGFRm) NSCLC in Phase 1/2 SYMPHONY Study

Saved in:
Bibliographic Details
Main Authors: Y. Elamin, M. Nagasaka, E. Shum, L. Bazhenova, J. Rotow, D.R. Spigel, D.S.W. Tan, A. Zalutskaya, F. Albayya, K.L. Reckamp
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:The Journal of Liquid Biopsy
Online Access:http://www.sciencedirect.com/science/article/pii/S295019542300125X
Tags: Add Tag
No Tags, Be the first to tag this record!